Teva Pharmaceutical Industries Ltd (TEVA): Depreciation & Amortization
$1.00B
Year ended 2025-12-31
$988.00M
Trailing 12 months to 2026-06-30
-8.5%
3-year compound annual growth
-8.4%
5-year compound annual growth
-2.6%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.00B | -5.4% | 2026-02-03, From 2025-01-01 |
| 2024-12-31 | $1.06B | -8.2% | 2026-02-03, From 2024-01-01 |
| 2023-12-31 | $1.15B | -11.9% | 2026-02-03, From 2023-01-01 |
| 2022-12-31 | $1.31B | -1.7% | 2025-02-05, From 2022-01-01 |
| 2021-12-31 | $1.33B | -14.6% | 2024-02-12, From 2021-01-01 |
| 2020-12-31 | $1.56B | -9.6% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $1.72B | -6.5% | 2022-02-09, From 2019-01-01 |
| 2018-12-31 | $1.84B | -12.8% | 2021-02-10, From 2018-01-01 |
| 2017-12-31 | $2.11B | +38.6% | 2020-02-21, From 2017-01-01 |
| 2016-12-31 | $1.52B | +16.5% | 2019-02-19, From 2016-01-07 |
| 2015-12-31 | $1.31B | -13.3% | 2018-02-12, From 2015-01-01 |
| 2014-12-31 | $1.51B | -8.2% | 2017-02-15, From 2014-01-01 |
| 2013-12-31 | $1.64B | -3.9% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $1.71B | +59.8% | 2015-02-09, From 2012-01-01 |
| 2011-12-31 | $1.07B | +9.4% | 2014-02-10, From 2011-01-01 |
| 2010-12-31 | $977.00M | +7.6% | 2013-02-12, From 2010-01-01 |
| 2009-12-31 | $908.00M | +85.3% | 2012-02-17, From 2009-01-01 |
| 2008-12-31 | $490.00M | -1.8% | 2011-02-15, From 2008-01-01 |
| 2007-12-31 | $499.00M | n/a | 2010-02-22, From 2007-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.00B | -5.4% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $543.70M | +12.6% |
| Viatris Inc (VTRS) | 2025-12-31 | $2.80B | -3.3% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $209.80M | +1.3% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.21B | -4.7% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $487.00M | -2.0% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $4.01B | -58.2% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $141.69M | -17.5% |
| Pfizer Inc (PFE) | 2025-12-31 | $6.59B | -6.0% |
Compare TEVA, REGN, VTRS, VRTX side by side · Screen every company in Pharmaceutical Preparations ↗